课题基金 / 基金详情

Exploiting Caenorhabditis elegans as a Platform for Novel Drug and Target Discovery

Exploiting Caenorhabditis elegans as a Platform for Novel Drug and Target Discovery
利用秀丽隐杆线虫作为新药和靶点发现的平台
批准号:
293169
负责人:
Roy Peter J
金额:
$90.04万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-09-01 至 2018-09-01

项目摘要

项目成果

Roy Peter J的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We propose to continue our CIHR-funded work to identify new potential drugs for two human diseases. Towards this end, we use the tiny nematode worm, C. elegans, as a model system because it is easy to do experiments with and because more than 70% of its
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PEXIL- A Novel Massively Parallel Drug Screening Technology to Identify Compounds to Combat Multiple Human Pathogens
  • 批准号:
    468542
  • 项目类别:
    Operating Grants
  • 资助金额:
    $83.32万
  • 财政年份:
    2022
  • 负责人:
    Roy Peter J
  • 依托单位:
Canada Reseach Chair - Tier 1
  • 批准号:
    454239
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2021
  • 负责人:
    Roy Peter J
  • 依托单位:
The Development of Novel Neuroactive Compounds to Combat Parasitic Nematodes
  • 批准号:
    418979
  • 项目类别:
    Operating Grants
  • 资助金额:
    $58.52万
  • 财政年份:
    2020
  • 负责人:
    Roy Peter J
  • 依托单位:
Understanding the Plasma Membrane as a Barrier to Drug Accumulation and Nutrient Absorption
  • 批准号:
    356507
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.73万
  • 财政年份:
    2016
  • 负责人:
    Roy Peter J
  • 依托单位:
海外基金